Molecular evidence for mitochondrial dysfunction in bipolar disorder.
暂无分享,去创建一个
Stephan Heckers | F. Benes | S. Heckers | C. Konradi | Christine Konradi | Francine M Benes | Matthew L MacDonald | Molly Eaton | John Walsh | M. MacDonald | J. Walsh | M. Eaton | Molly E. Eaton
[1] Jun-Feng Wang,et al. Gene expression differences in bipolar disorder revealed by cDNA array analysis of post‐mortem frontal cortex , 2001, Journal of neurochemistry.
[2] F. Benes,et al. Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia. , 2002, Archives of general psychiatry.
[3] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[4] Steven C. Lawlor,et al. GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways , 2002, Nature Genetics.
[5] G. Buzsáki,et al. Interneurons of the hippocampus , 1998, Hippocampus.
[6] F. McMahon,et al. Increased levels of a mitochondrial DNA deletion in the brain of patients with bipolar disorder , 1997, Biological Psychiatry.
[7] Wei-Hua Wu,et al. Modulation of ATP-Dependent Chromatin-Remodeling Complexes by Inositol Polyphosphates , 2002, Science.
[8] S. Rapoport,et al. Analysis of gene expression with cDNA microarrays in rat brain after 7 and 42 days of oral lithium administration , 2002, Brain Research Bulletin.
[9] Yarema Bezchlibnyk,et al. The Neurobiology of Bipolar Disorder: Focus on Signal Transduction Pathways and the Regulation of Gene Expression , 2002, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[10] F. Goodwin. Manic-Depressive Illness , 1990 .
[11] D. Wallace. Mitochondrial diseases in man and mouse. , 1999, Science.
[12] W. Hörz,et al. ATP-dependent nucleosome remodeling. , 2002, Annual review of biochemistry.
[13] G. Fein,et al. Decreased temporal lobe phosphomonoesters in bipolar disorder. , 1995, Journal of affective disorders.
[14] H. Möller,et al. Evidence for a mitochondrial oxidative phosphorylation defect in brains from patients with schizophrenia , 2001, Schizophrenia Research.
[15] M. Guenther,et al. Histone Deacetylase Is a Direct Target of Valproic Acid, a Potent Anticonvulsant, Mood Stabilizer, and Teratogen* , 2001, The Journal of Biological Chemistry.
[16] W. Cowan,et al. The human genome project and its impact on psychiatry. , 2002, Annual review of neuroscience.
[17] T. Inubushi,et al. Alterations in brain phosphorous metabolism in bipolar disorder detected by in vivo 31P and 7Li magnetic resonance spectroscopy. , 1993, Journal of affective disorders.
[18] J. Prince,et al. A histochemical demonstration of altered cytochrome oxidase activity in the rat brain by neuroleptics , 1998, European Neuropsychopharmacology.
[19] S. Budd,et al. Mitochondria and neuronal survival. , 2000, Physiological reviews.
[20] J. Kelly,et al. Neuroleptic medications inhibit complex I of the electron transport chain , 1993, Annals of neurology.
[21] C. Allis,et al. The language of covalent histone modifications , 2000, Nature.
[22] M. Mimmack,et al. Quantitative polymerase chain reaction: validation of microarray results from postmortem brain studies , 2004, Biological Psychiatry.
[23] J. Pierri,et al. Gene Expression Profiling Reveals Alterations of Specific Metabolic Pathways in Schizophrenia , 2002, The Journal of Neuroscience.
[24] A. Guidotti,et al. An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[25] J. Mesirov,et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.
[26] N. Kato,et al. Magnetic resonance spectroscopy in affective disorders. , 1998, The Journal of neuropsychiatry and clinical neurosciences.
[27] M. Ehlers. Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system , 2003, Nature neuroscience.
[28] Yogesh K. Dwivedi,et al. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. , 2000, Archives of general psychiatry.
[29] J. Feighner,et al. Diagnostic criteria for use in psychiatric research. , 1972, Archives of general psychiatry.
[30] Emil Kraepelin,et al. Psychiatry : A Textbook for Students and Physicians , 1990 .
[31] J. Prince,et al. Normalization of cytochrome-c oxidase activity in the rat brain by neuroleptics after chronic treatment with PCP or methamphetamine , 1997, Neuropharmacology.
[32] N. Kato,et al. Mitochondrial dysfunction in bipolar disorder. , 2000, Bipolar disorders.
[33] H. Manji,et al. Molecular mechanisms underlying mood stabilization in manic-depressive illness: the phenotype challenge. , 1999, The American journal of psychiatry.
[34] C. Li,et al. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. , 2001, Proceedings of the National Academy of Sciences of the United States of America.